Cargando…
Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay
BACKGROUND AND AIM: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells through the binding of the viral spike protein with human angiotensin-converting enzyme 2 (ACE2), resulting in the development of coronavirus disease 2019 (COVID-19). To date, few antiviral drugs are availa...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443859/ https://www.ncbi.nlm.nih.gov/pubmed/34549024 http://dx.doi.org/10.1016/j.jtcme.2021.09.002 |
_version_ | 1784568379890204672 |
---|---|
author | Chen, Guan-Yu Pan, Yi-Cheng Wu, Tung-Ying Yao, Tsung-You Wang, Wei-Jan Shen, Wan-Jou Ahmed, Azaj Chan, Shu-Ting Tang, Chih-Hsin Huang, Wei-Chien Hung, Mien-Chie Yang, Juan-Cheng Wu, Yang-Chang |
author_facet | Chen, Guan-Yu Pan, Yi-Cheng Wu, Tung-Ying Yao, Tsung-You Wang, Wei-Jan Shen, Wan-Jou Ahmed, Azaj Chan, Shu-Ting Tang, Chih-Hsin Huang, Wei-Chien Hung, Mien-Chie Yang, Juan-Cheng Wu, Yang-Chang |
author_sort | Chen, Guan-Yu |
collection | PubMed |
description | BACKGROUND AND AIM: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells through the binding of the viral spike protein with human angiotensin-converting enzyme 2 (ACE2), resulting in the development of coronavirus disease 2019 (COVID-19). To date, few antiviral drugs are available that can effectively block viral infection. This study aimed to identify potential natural products from Taiwan Database of Extracts and Compounds (TDEC) that may prevent the binding of viral spike proteins with human ACE2 proteins. METHODS: The structure-based virtual screening was performed using the AutoDock Vina program within PyRX software, the binding affinities of compounds were verified using isothermal titration calorimetry (ITC), the inhibitions of SARS-CoV-2 viral infection efficacy were examined by lentivirus particles pseudotyped (Vpp) infection assay, and the cell viability was tested by 293T cell in MTT assay. RESULTS AND CONCLUSION: We identified 39 natural products targeting the viral receptor-binding domain (RBD) of the SARS-CoV-2 spike protein in silico. In ITC binding assay, dioscin, celastrol, saikosaponin C, epimedin C, torvoside K, and amentoflavone showed dissociation constant (K(d)) = 0.468 μM, 1.712 μM, 6.650 μM, 2.86 μM, 3.761 μM and 4.27 μM, respectively. In Vpp infection assay, the compounds have significantly and consistently inhibition with the 50–90% inhibition of viral infection efficacy. In cell viability, torvoside K, epimedin, amentoflavone, and saikosaponin C showed IC(50) > 100 μM; dioscin and celastrol showed IC(50) = 1.5625 μM and 0.9866 μM, respectively. These natural products may bind to the viral spike protein, preventing SARS-CoV-2 from entering cells. SECTION: 1: Natural Products. TAXONOMY (CLASSIFICATION BY EVISE): SARS-CoV-2, Structure-Based Virtual Screening, Isothermal Titration Calorimetry and Lentivirus Particles Pseudotyped (Vpp) Infection Assay, in silico and in vitro study. |
format | Online Article Text |
id | pubmed-8443859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84438592021-09-16 Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay Chen, Guan-Yu Pan, Yi-Cheng Wu, Tung-Ying Yao, Tsung-You Wang, Wei-Jan Shen, Wan-Jou Ahmed, Azaj Chan, Shu-Ting Tang, Chih-Hsin Huang, Wei-Chien Hung, Mien-Chie Yang, Juan-Cheng Wu, Yang-Chang J Tradit Complement Med Article BACKGROUND AND AIM: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells through the binding of the viral spike protein with human angiotensin-converting enzyme 2 (ACE2), resulting in the development of coronavirus disease 2019 (COVID-19). To date, few antiviral drugs are available that can effectively block viral infection. This study aimed to identify potential natural products from Taiwan Database of Extracts and Compounds (TDEC) that may prevent the binding of viral spike proteins with human ACE2 proteins. METHODS: The structure-based virtual screening was performed using the AutoDock Vina program within PyRX software, the binding affinities of compounds were verified using isothermal titration calorimetry (ITC), the inhibitions of SARS-CoV-2 viral infection efficacy were examined by lentivirus particles pseudotyped (Vpp) infection assay, and the cell viability was tested by 293T cell in MTT assay. RESULTS AND CONCLUSION: We identified 39 natural products targeting the viral receptor-binding domain (RBD) of the SARS-CoV-2 spike protein in silico. In ITC binding assay, dioscin, celastrol, saikosaponin C, epimedin C, torvoside K, and amentoflavone showed dissociation constant (K(d)) = 0.468 μM, 1.712 μM, 6.650 μM, 2.86 μM, 3.761 μM and 4.27 μM, respectively. In Vpp infection assay, the compounds have significantly and consistently inhibition with the 50–90% inhibition of viral infection efficacy. In cell viability, torvoside K, epimedin, amentoflavone, and saikosaponin C showed IC(50) > 100 μM; dioscin and celastrol showed IC(50) = 1.5625 μM and 0.9866 μM, respectively. These natural products may bind to the viral spike protein, preventing SARS-CoV-2 from entering cells. SECTION: 1: Natural Products. TAXONOMY (CLASSIFICATION BY EVISE): SARS-CoV-2, Structure-Based Virtual Screening, Isothermal Titration Calorimetry and Lentivirus Particles Pseudotyped (Vpp) Infection Assay, in silico and in vitro study. Elsevier 2021-09-16 /pmc/articles/PMC8443859/ /pubmed/34549024 http://dx.doi.org/10.1016/j.jtcme.2021.09.002 Text en © 2021 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Chen, Guan-Yu Pan, Yi-Cheng Wu, Tung-Ying Yao, Tsung-You Wang, Wei-Jan Shen, Wan-Jou Ahmed, Azaj Chan, Shu-Ting Tang, Chih-Hsin Huang, Wei-Chien Hung, Mien-Chie Yang, Juan-Cheng Wu, Yang-Chang Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay |
title | Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay |
title_full | Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay |
title_fullStr | Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay |
title_full_unstemmed | Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay |
title_short | Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay |
title_sort | potential natural products that target the sars-cov-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (vpp) infection assay |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443859/ https://www.ncbi.nlm.nih.gov/pubmed/34549024 http://dx.doi.org/10.1016/j.jtcme.2021.09.002 |
work_keys_str_mv | AT chenguanyu potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT panyicheng potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT wutungying potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT yaotsungyou potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT wangweijan potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT shenwanjou potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT ahmedazaj potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT chanshuting potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT tangchihhsin potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT huangweichien potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT hungmienchie potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT yangjuancheng potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay AT wuyangchang potentialnaturalproductsthattargetthesarscov2spikeproteinidentifiedbystructurebasedvirtualscreeningisothermaltitrationcalorimetryandlentivirusparticlespseudotypedvppinfectionassay |